{"slug":"selank-benzo-withdrawal","title":"selank benzo withdrawal","body":"## Regeneration vs degeneration — where this fits\n\nbenzo withdrawal represents tissue breakdown exceeding repair capacity. Most interventions manage symptoms. This article examines whether selank mechanisms address underlying repair deficits.\n\n## What is known\n\nStudied for anxiolytic pathways without classic benzodiazepine sedation.\n\nTarget condition: benzo withdrawal.\nBody system: GABA / CNS.\n\n## Logic chain\n\n1. selank studied for anxiolytic pathways without classic benzodiazepine sedation..\n2. benzo withdrawal involves gaba / cns dysfunction.\n3. If selank reaches the affected tissue, it may shift the repair/breakdown balance.\n4. This chain is tested in animal or lab models only.\n\n## Parent peptide claims relevant here\n\n- In a 2008 randomized study of 62 patients with GAD and neurasthenia, Selank showed anxiolytic efficacy comparable to medazepam on psychometric scales without reported sedation, cognitive impairment, tolerance or withdrawal.\n- Selank administration in rats alters expression of 45 neurotransmission-related genes at 1 hour and 22 genes at 3 hours, with positive correlation to GABA effects.\n- Commercial vendors and clinics market this compound (7 commercial/clinic sources catalogued) — marketing material, not evidence.\n- 2017 study showing Selank's anxiolytic effects comparable to benzodiazepines in rat stress model.\n- 2019 rat study on Selank protecting against alcohol-related memory issues via BDNF regulation.\n\n## Evidence tier\n\nPreclinical — animal and in vitro studies only. No published human trials for this specific combination.\n\n## What we do not know\n\n- Whether selank reaches benzo withdrawal tissue at functional concentrations\n- Optimal dosing, route, and duration for this target\n- Interaction with standard-of-care treatments for benzo withdrawal\n- Long-term safety profile in this population\n\n## Safety note\n\nAll peptide use for benzo withdrawal is research-context only. Not medical advice. Consult a physician before any experimental compound.","register":"standard","tags":["peptide"],"category":null,"style":{},"claims":[{"id":"c_map_selank-benzo-withdrawal","text":"Combinatorial mapping (transparent): selank vs benzo-withdrawal — regen=0.717, degen=0.7, Δ=0.017. Method: layer_relevance(0.75) × evidence_factor(0.85); catalog.degen_score for Benzodiazepine withdrawal.","section":"what_is_known","tier":"system"}],"sources":[],"prov":{"model":"grok/grok-4.3","action":"write"}}